Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Foxp3 promotes macrophage phagocytosis in AIS

ABSTRACT: Foxp3 promotes macrophage phagocytosis in AIS

PROVIDER: PRJNA852849 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19851102_1.fastq.gz	Fastqsanger.gz
	SRR19851102_2.fastq.gz	Fastqsanger.gz
	SRR19851103_1.fastq.gz	Fastqsanger.gz
	SRR19851103_2.fastq.gz	Fastqsanger.gz
	SRR19851104_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 22

Similar Datasets

ozone-derived oxisterols impair lung macrophage phagocytosis via adduction of phagocytosis receptors

Project description:Inhalation of the amibient air polution ozone causes lung inflammation and can suppress host defense mechanisms, including impairing macrophage phagocytosis. Ozone reacts with cholesterol in the lung to form oxysterols, like secosterol A and secosterol B, which can form covalent adducts on cellular proteins. How oxysterol-protein adduction modifies the function of lung macrophages is unknown. Herein, we used a preoteomic screen to identify lung macrophage proteins that fomr adducts with ozone-derived oxysterols. Analysis show that the phagocytic receptor CD206 and CD64 formed adducts with secosterol A. Adduction of these receptors with ozone-derived oxysterols impaired ligand binding and corresponded with reduced macrophage phagocytosis. This work suggests a novle mechanism for the suppression of macrophage phagocytosis following ozone exposure through the generation of oxysterols and the formation of oxysterol-protein adducts on phagocytic receptors.

2020-07-18 | PXD019317 | Pride

THP-1 derived macrophage samples with phagocytosis and non-phagocytosis of tumor cells

Project description:THP-1 derived macrophage samples with phagocytosis and non-phagocytosis of tumor cells (duplicates for each condition).

2025-07-15 | GSE268430 | GEO

Foxp3 promotes macrophage phagocytosis in AIS

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-12-31 | GSE206946 | GEO

Response of M. guilliermondii to macrophage phagocytosis

Project description:Response of M. guilliermondii to macrophage phagocytosis

| PRJNA636086 | ENA

THP-1 derived macrophage samples with phagocytosis and non-phagocytosis of tumor cells

Project description:THP-1 derived macrophage samples with phagocytosis and non-phagocytosis of tumor cells

| PRJNA1117360 | ENA

Neutrophil Death Medicates Alveolar Macrophage Proliferation and Phagocytosis

Project description:Neutrophil Death Medicates Alveolar Macrophage Proliferation and Phagocytosis

| PRJNA873918 | ENA

Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice

Project description:Ras homolog enriched in brain (Rheb1) is a small GTPase and is known to be a direct activator of mTORC1. Dysregulation of Rheb1 has been shown to impair the cellular-energetic state and cell homeostasis. However, the role of Rheb1 in monocytes/macrophages differentiation and maturation is not clear. Here, we investigate the role of Rheb1 in mouse myelopoiesis using a Rheb1 conditional deletion murine model. We found that the absolute number of macrophages decreased in the bone marrow (BM) of Rheb1-deficient mice. Loss of Rheb1 inhibited the monocyte-to-macrophage differentiation process. Additionally, Rheb1 deletion reduced phagocytosis ability of macrophages by inhibiting the mTORC1 signaling pathway. Furthermore, 3BDO (an activator of mTORC1) rescued the phagocytosis ability of Rheb1-deficient macrophages. Thus, Rheb1 is critical for macrophage production and phagocytosis and executes these activities possibly via mTORC1-dependent pathway.

2018-03-23 | GSE79538 | GEO

Targeting CD37 promotes phagocytosis against multi cancer cell

Project description:Macrophages play vital roles in innate and adaptive immunity, and their indispensable functions are accomplished by phagocytosis and antigen presentation. Great efforts have been made to explore the potential mechanism of action of potential phagocytosis checkpoints. However, the use of a systematic checkpoint scanning strategy is far from satisfactory. We thus established an in vitro phagocytosis assay using primary healthy donors’ macrophages and breast cancer cells. Equal numbers of cells were sorted and subjected to ribosome profiling, and immune system-specific checkpoints were ultimately identified. CD37 was dramatically downregulated in phagocytic macrophages and targeting CD37 with a specific antibody promoted phagocytosis of multiple cancer cells. Tumorous macrophage migration inhibitory factor (MIF) directly binds to CD37 and promotes the recruitment of SHP1. Targeting CD37 enhances the efficacy of CD47 in vivo and in vitro. In all, our study identified a previously unidentified phagocytosis checkpoint and provided new potential for precise therapy.

2025-06-04 | PXD061433 |

Red blood cells from mice on high fat diet induce macrophage activation during phagocytosis

Project description:We studied macrophage gene expression from mice fed chow diet (C) or 60% high fat diet (HF), that phagocytized C-RBC, HFD-RBC, or no RBC. Macrophages from mice on HF diet were activated toward a pro-inflammatory phenotype. In macrophages isolated from CD mice, RBC phagocytosis yielded a gene expression pattern similar to HF macrophages. Incubation of HF-RBC with macrophages resulted in a significantly more pronounced upregulation of pro-inflammatory chemokines as compared to C-RBC. Peritoneal macrophages were obtained from C57BL/6 mice fed either C or HF diet. Phagocytosis was performed in vitro with C-RBC or HF-RBC; macrophages not exposed to RBC served as a control. Affymetrix Mouse Gene 1.0 ST microarray chips were used to assess the gene expression profile.

2013-08-28 | E-GEOD-50240 | biostudies-arrayexpress

IL4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation

Project description:Cytokines are key regulators of tumor immune surveillance by controlling immune cell activity. Here, we investigated whether interleukin 4 (IL4) has antileukemic activity via immune-mediated mechanisms in an in vivo murine model of acute myeloid leukemia driven by the MLL-AF9 fusion gene. Although IL4 strongly inhibited leukemia development in immunocompetent mice, the effect was diminished in immune-deficient recipient mice, demonstrating that the antileukemic effect of IL4 in vivo is dependent on the host immune system. Using flow cytometric analysis and immunohistochemistry, we revealed that the antileukemic effect of IL4 coincided with an expansion of F4/80+ macrophages in the bone marrow and spleen. To elucidate whether this macrophage expansion was responsible of the antileukemic effect, we depleted macrophages in vivo with clodronate liposomes. Macrophage depletion eliminated the antileukemic effect of IL4, showing that macrophages mediated the IL4-induced killing of leukemia cells. In addition, IL4 enhanced murine macrophage-mediated phagocytosis of leukemia cells in vitro. Global transcriptomic analysis of macrophages revealed an enrichment of signatures associated with alternatively activated macrophages and increased phagocytosis upon IL4 stimulation. Notably, IL4 concurrently induced Stat6-dependent upregulation of CD47 on leukemia cells, which suppressed macrophage activity. Consistent with this finding, combining CD47 blockade with IL4 stimulation enhanced macrophage-mediated phagocytosis of leukemia cells. Thus, IL4 has two counteracting roles in regulating phagocytosis in mice; enhancing macrophage-mediated killing of leukemia cells, but also inducing CD47 expression that protects target cells from excessive phagocytosis. Taken together, our data suggests that combined strategies that activate macrophages and block CD47 have therapeutic potential in AML.

2021-07-14 | GSE155048 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data